valsartan and hydrochlorothiazide
Generic: valsartan and hydrochlorothiazide
Labeler: macleods pharmaceuticals limitedDrug Facts
Product Profile
Brand Name
valsartan and hydrochlorothiazide
Generic Name
valsartan and hydrochlorothiazide
Labeler
macleods pharmaceuticals limited
Dosage Form
TABLET, FILM COATED
Routes
Active Ingredients
hydrochlorothiazide 12.5 mg/1, valsartan 160 mg/1
Manufacturer
Identifiers & Regulatory
Product NDC
33342-075
Product ID
33342-075_a1b947a6-e356-4442-9df7-9e82b299a852
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA203145
Listing Expiration
2026-12-31
Marketing Start
2013-04-19
Pharmacologic Class
Established (EPC)
Mechanism of Action
Chemical Structure
Physiologic Effect
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
33342075
Hyphenated Format
33342-075
Supplemental Identifiers
RxCUI
UPC
UNII
NUI
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
valsartan and hydrochlorothiazide (source: ndc)
Generic Name
valsartan and hydrochlorothiazide (source: ndc)
Application Number
ANDA203145 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 12.5 mg/1
- 160 mg/1
Packaging
- 90 TABLET, FILM COATED in 1 BOTTLE (33342-075-10)
- 500 TABLET, FILM COATED in 1 BOTTLE (33342-075-15)
Packages (2)
Ingredients (2)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "a1b947a6-e356-4442-9df7-9e82b299a852", "openfda": {"nui": ["N0000175359", "N0000175419", "M0471776", "N0000000070", "N0000175561"], "upc": ["0333342075109", "0333342074102", "0333342076106", "0333342077103"], "unii": ["0J48LPH2TH", "80M03YXJ7I"], "rxcui": ["200284", "200285", "349353", "636042", "636045"], "spl_set_id": ["771afba6-8769-4ea8-afec-358dba0aaefe"], "pharm_class_cs": ["Thiazides [CS]"], "pharm_class_pe": ["Increased Diuresis [PE]"], "pharm_class_epc": ["Thiazide Diuretic [EPC]", "Angiotensin 2 Receptor Blocker [EPC]"], "pharm_class_moa": ["Angiotensin 2 Receptor Antagonists [MoA]"], "manufacturer_name": ["Macleods Pharmaceuticals Limited"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "90 TABLET, FILM COATED in 1 BOTTLE (33342-075-10)", "package_ndc": "33342-075-10", "marketing_start_date": "20130419"}, {"sample": false, "description": "500 TABLET, FILM COATED in 1 BOTTLE (33342-075-15)", "package_ndc": "33342-075-15", "marketing_start_date": "20130419"}], "brand_name": "Valsartan and Hydrochlorothiazide", "product_id": "33342-075_a1b947a6-e356-4442-9df7-9e82b299a852", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["Angiotensin 2 Receptor Antagonists [MoA]", "Angiotensin 2 Receptor Blocker [EPC]", "Increased Diuresis [PE]", "Thiazide Diuretic [EPC]", "Thiazides [CS]"], "product_ndc": "33342-075", "generic_name": "Valsartan and Hydrochlorothiazide", "labeler_name": "Macleods Pharmaceuticals Limited", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Valsartan and Hydrochlorothiazide", "active_ingredients": [{"name": "HYDROCHLOROTHIAZIDE", "strength": "12.5 mg/1"}, {"name": "VALSARTAN", "strength": "160 mg/1"}], "application_number": "ANDA203145", "marketing_category": "ANDA", "marketing_start_date": "20130419", "listing_expiration_date": "20261231"}